News ResMed, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 31/05/2024 BST			5-day change	1st Jan Change
206.3 ^USD	-1.44%		-3.25%	+19.95%

05-23	ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea	MT
05-14	Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM

ResMed : Third Quarter 2024 Transcript	05-23	PU
ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea	05-23	MT
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy	05-23	GL
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy	05-16	GL
Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM	05-14
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	05-10	MT
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing	05-09	MT
Ex-dividend day	05-07	FA
ResMed Announces Participation in the RBCCM Global Healthcare Conference	05-07	GL
ResMed : Q3 2024 ResMed Earnings Results Webcast Transcript	04-30	PU
Morgans rates RMD as Add	04-29	AQ
ResMed Silences The Doubters	04-29	AQ
Sector Update: Health Care Stocks Edge Higher Late Afternoon	04-26	MT
Top Midday Gainers	04-26	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	04-26	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	04-26	MT
Sector Update: Health Care	04-26	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	04-26	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	04-26	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	04-26	MT

No results for this search

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 10:55 am